🇺🇸 FDA
Patent

US 12030911

Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA

granted A61PA61P21/00

Quick answer

US patent 12030911 (Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P21/00